<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35355237</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-0973</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Infection</Title><ISOAbbreviation>Infection</ISOAbbreviation></Journal><ArticleTitle>Obesity and lipid metabolism disorders determine the risk for development of long COVID syndrome: a cross-sectional study from 50,402 COVID-19 patients.</ArticleTitle><Pagination><StartPage>1165</StartPage><EndPage>1170</EndPage><MedlinePgn>1165-1170</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s15010-022-01784-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Metabolic disorders have been identified as major risk factors for severe acute courses of COVID-19. With decreasing numbers of infections in many countries, the long COVID syndrome (LCS) represents the next major challenge in pandemic management, warranting the precise definition of risk factors for LCS development.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We identified 50,402 COVID-19 patients in the Disease Analyzer database (IQVIA) featuring data from 1056 general practices in Germany. Multivariate logistic regression analysis was used to identify risk factors for the development of LCS.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 50,402 COVID-19 patients included into this analysis, 1,708 (3.4%) were diagnosed with LCS. In a multivariate regression analysis, we identified lipid metabolism disorders (OR 1.46, 95% CI 1.28-1.65, p&#x2009;&lt;&#x2009;0.001) and obesity (OR 1.25, 95% CI 1.08-1.44, p&#x2009;=&#x2009;0.003) as strong risk factors for the development of LCS. Besides these metabolic factors, patients' age between 46 and 60&#xa0;years (compared to age&#x2009;&#x2264;&#x2009;30, (OR 1.81 95% CI 1.54-2.13, p&#x2009;&lt;&#x2009;0.001), female sex (OR 1.33, 95% CI 1.20-1.47, p&#x2009;&lt;&#x2009;0.001) as well as pre-existing asthma (OR 1.67, 95% CI 1.39-2.00, p&#x2009;&lt;&#x2009;0.001) and depression (OR 1.27, 95% CI 1.09-1.47, p&#x2009;=&#x2009;&lt;&#x2009;0.002) in women, and cancer (OR 1.4, 95% CI 1.09-1.95, p&#x2009;=&#x2009;&lt;&#x2009;0.012) in men were associated with an increased likelihood of developing LCS.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Lipid metabolism disorders and obesity represent age-independent risk factors for the development of LCS, suggesting that metabolic alterations determine the risk for unfavorable disease courses along all phases of COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Loosen</LastName><ForeName>Sven H</ForeName><Initials>SH</Initials><Identifier Source="ORCID">0000-0002-2799-2287</Identifier><AffiliationInfo><Affiliation>Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital D&#xfc;sseldorf, Medical Faculty of Heinrich Heine University D&#xfc;sseldorf, Moorenstra&#xdf;e 5, 40225, D&#xfc;sseldorf, Germany. Sven.Loosen@med.uni-duesseldorf.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jensen</LastName><ForeName>Bj&#xf6;rn-Erik Ole</ForeName><Initials>BO</Initials><AffiliationInfo><Affiliation>Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital D&#xfc;sseldorf, Medical Faculty of Heinrich Heine University D&#xfc;sseldorf, Moorenstra&#xdf;e 5, 40225, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanislav</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Geriatrics and Neurology, Diakonie Hospital Jung Stilling, Siegen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Luedde</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital D&#xfc;sseldorf, Medical Faculty of Heinrich Heine University D&#xfc;sseldorf, Moorenstra&#xdf;e 5, 40225, D&#xfc;sseldorf, Germany. luedde@hhu.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Roderburg</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital D&#xfc;sseldorf, Medical Faculty of Heinrich Heine University D&#xfc;sseldorf, Moorenstra&#xdf;e 5, 40225, D&#xfc;sseldorf, Germany. Christoph.Roderburg@med.uni-duesseldorf.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kostev</LastName><ForeName>Karel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Epidemiology, QVIA, Frankfurt, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Infection</MedlineTA><NlmUniqueID>0365307</NlmUniqueID><ISSNLinking>0300-8126</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050356" MajorTopicYN="N">Lipid Metabolism</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052439" MajorTopicYN="Y">Lipid Metabolism Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BMI</Keyword><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">LCS</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>5</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35355237</ArticleId><ArticleId IdType="pmc">PMC8966865</ArticleId><ArticleId IdType="doi">10.1007/s15010-022-01784-0</ArticleId><ArticleId IdType="pii">10.1007/s15010-022-01784-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johns Hopkins Coronavirus Resource Center (2020) COVID-19 map. https://coronavirus.jhu.edu/map.html. Accessed 15 May 2020</Citation></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021 doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. The BMJ. 2021 doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed 2 Nov 2021</Citation></Reference><Reference><Citation>Rathmann W, Bongaerts B, Carius HJ, Kruppert S, Kostev K. Basic characteristics and representativeness of the German disease analyzer database. Int J Clin Pharmacol Ther. 2018;56:459&#x2013;466. doi: 10.5414/CP203320.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CP203320</ArticleId><ArticleId IdType="pubmed">30168417</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappetta S, Sharma AM, Bottino V, Stier C. COVID-19 and the role of chronic inflammation in patients with obesity. Int J Obes. 2020;44:1790&#x2013;1792. doi: 10.1038/s41366-020-0597-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-020-0597-4</ArticleId><ArticleId IdType="pmc">PMC7224343</ArticleId><ArticleId IdType="pubmed">32409680</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Chi J, Lv W, Wang Y. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19) Diabetes Metab Res Rev. 2021 doi: 10.1002/dmrr.3377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3377</ArticleId><ArticleId IdType="pmc">PMC7361201</ArticleId><ArticleId IdType="pubmed">32588943</ArticleId></ArticleIdList></Reference><Reference><Citation>Holman N, Knighton P, Kar P, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8:823&#x2013;833. doi: 10.1016/S2213-8587(20)30271-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(20)30271-0</ArticleId><ArticleId IdType="pmc">PMC7426091</ArticleId><ArticleId IdType="pubmed">32798471</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschenberger M, Hunszinger V, Sparrer KMJ. Implications of innate immunity in post-acute sequelae of non-persistent viral infections. Cells. 2021 doi: 10.3390/cells10082134.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082134</ArticleId><ArticleId IdType="pmc">PMC8391718</ArticleId><ArticleId IdType="pubmed">34440903</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P, Gunnes N, Tveito K, Bakken IJ, Ghaderi S, Stoltenberg C, Hornig M, Lipkin WI, Trogstad L, H&#xe5;berg SE. Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33:6173&#x2013;6177. doi: 10.1016/j.vaccine.2015.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.10.018</ArticleId><ArticleId IdType="pubmed">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegers JY, Novakovic B, Hulme KD, et al. A high-fat diet increases influenza a virus-associated cardiovascular damage. J Infect Dis. 2020;222:820&#x2013;831. doi: 10.1093/infdis/jiaa159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiaa159</ArticleId><ArticleId IdType="pubmed">32246148</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M, Honce R, Schultz-Cherry S. Metabolic syndrome and viral pathogenesis: lessons from influenza and coronaviruses. J Virol. 2020 doi: 10.1128/jvi.00665-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.00665-20</ArticleId><ArticleId IdType="pmc">PMC7459568</ArticleId><ArticleId IdType="pubmed">32661141</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagliabue C, Principi N, Giavoli C, Esposito S. Obesity: impact of infections and response to vaccines. Eur J Clin Microbiol Infect Dis. 2016;35:325&#x2013;331. doi: 10.1007/s10096-015-2558-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-015-2558-8</ArticleId><ArticleId IdType="pubmed">26718941</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health-Eur. 2021 doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health-Eur. 2021 doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Vimercati L, de Maria L, Quarato M, et al. Association between long COVID and overweight/obesity. J Clin Med. 2021 doi: 10.3390/jcm10184143.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184143</ArticleId><ArticleId IdType="pmc">PMC8469321</ArticleId><ArticleId IdType="pubmed">34575251</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>